InvestorsHub Logo

loanranger

10/21/21 5:35 AM

#379559 RE: kfcyahoo #379550

"Economic rape is, apparently, the new business model."

The model hasn't changed here...pricing is based on what the market will bear. Merck knows, as should we, that the US is a VERY soft touch. Its government will pay whatever it has to to get what it wants, even when the difference between what it pays and what underdeveloped countries pay (which is based on what they CAN pay) is as crazy as the current example.

Besides, the pharmaceutical industry has never been the place to look for "reasonable" when it comes to mark-ups and if anyone tries to sell the "10% overhead, 10% profit" to a drug exec they better be ready for a big earful of "What about all of that R&D money spent on this drug and on all the products that failed?".